title: Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis-reply to Pazianas and Abrahamsen.
authors.affiliation: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, M5S 3M2, Canada, mina.tadrous@utoronto.ca.
authors.forename: M
authors.initials: M
authors.lastname: Tadrous
authors.forename: M M
authors.initials: MM
authors.lastname: Mamdani
authors.forename: D N
authors.initials: DN
authors.lastname: Juurlink
authors.forename: M D
authors.initials: MD
authors.lastname: Krahn
authors.forename: L E
authors.initials: LE
authors.lastname: Lévesque
authors.forename: S M
authors.initials: SM
authors.lastname: Cadarette
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates